• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

byDonna LeetandAliya Ramjaun
April 6, 2019
in Chronic Disease, Emergency, Imaging and Intervention, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Intravenous thrombolytic therapy with alteplase (recombinant human tissue plasminogen activator) is approved for the treatment of acute ischemic stroke. However, whether it is efficacious in the treatment of lacunar infarcts remains unclear. In this secondary post-hoc analysis of the WAKE-UP randomized controlled trial, 108 patients with acute lacunar stroke from the original study population of 503 patients with an acute stroke of unknown onset time were studied to determine the efficacy and safety of intravenous thrombolysis with alteplase as compared to placebo among patients with lacunar infarcts. The primary endpoint was a favorable outcome defined as a score of 0 or 1 point on the modified Rankin Scale (mRS) at 90 days after stroke, adjusted for age and severity of symptoms. Compared to patients with non-lacunar infarcts, patients with lacunar infarcts were more likely to be male (68.5% vs. 63.5%), younger (mean age 63 years vs. 66 years, p=0.003), and to have a lower median National Institutes of Health Stroke Scale (NIHSS) score on admission (5 vs. 6, p<0.001). In total, 55 of the 108 patients with a lacunar infarct (50.9%) were assigned to receive alteplase, and 49.1% were assigned to receive placebo. Among all 503 patients, alteplase treatment was associated with higher odds of favorable outcome, with no differences observed between lacunar infarcts and non-lacunar infarcts (OR 1.68 vs.1.62, respectively, test for interaction, p=0.94). In patients with lacunar stroke, there was no significant difference in the proportion of patients achieving a favorable outcome in the alteplase group as compared to the placebo group (59% vs. 46%, respectively, OR 1.67, 95% CI 0.77 to 3.64, p=0.20). At 90 days, there was a non-significant difference in outcomes based on the distribution of mRS scores at 90 days (OR 1.94, 95% CI 0.95 to 3.93, p=0.07). In terms of safety, there was 1 death and 1 symptomatic intracranial hemorrhage in the alteplase group; neither of these outcomes occurred in the placebo group. Importantly, the WAKE-UP trial was not powered to show a significant treatment outcome in patient subgroups. Nonetheless, this study does show that the association of intravenous alteplase with functional outcome does not differ in patients with lacunar infarcts as compared to those experiencing other stroke subtypes.

Click to read the study in JAMA Neurology

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

2 Minute Medicine Rewind June 30, 2025

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

Tags: altepaselacunar infarctstrokethrombolysis
Previous Post

Quick Take: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial

Next Post

Quick Take: Outcomes of Extremely Preterm Infants With Birth Weight Less Than 400 g

RelatedReports

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Weekly Rewinds

2 Minute Medicine Rewind June 30, 2025

June 30, 2025
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Neurology

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

June 20, 2025
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Chronic Disease

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

June 4, 2025
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Chronic Disease

Personalized visual perceptual learning digital therapy may improve vision post-stroke

May 30, 2025
Next Post
Quick Take: Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: randomised placebo-controlled trial

Quick Take: Outcomes of Extremely Preterm Infants With Birth Weight Less Than 400 g

#VisualAbstract: Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer

#VisualAbstract: Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer

#VisualAbstract: A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

#VisualAbstract: A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
  • 2 Minute Medicine Rewind June 30, 2025
  • Weighted vests and resistance training confer similar outcomes for bone density in the elderly
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.